e-learning
resources
Virtual 2020
Pre-Congress Content
Inflammatory pathways in chronic airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
CARD9S12N allele expression imbalance favors development of allergic bronchopulmonary aspergillosis
X. Xu (Beijing, China), X. Jia (Shanghai, China), J. Xu (Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China, China)
Source:
Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases
Session:
Inflammatory pathways in chronic airway diseases
Session type:
E-poster session
Number:
917
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
X. Xu (Beijing, China), X. Jia (Shanghai, China), J. Xu (Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China, China). CARD9S12N allele expression imbalance favors development of allergic bronchopulmonary aspergillosis. 917
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Chemokine-receptor expression on allergen-specific T cells in allergic asthma and allergic bronchopulmonary aspergillosis
Source: Eur Respir J 2007; 30: Suppl. 51, 372s
Year: 2007
Airway remodelling easily develops in patients with allergic bronchopulmonary aspergillosis
Source: Annual Congress 2009 - Airways remodelling
Year: 2009
Treatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis
Source: Eur Respir J 2014; 43: 1487-1500
Year: 2014
Concurrent allergic bronchopulmonary aspergillosis and aspergilloma: is it a more severe form of the disease?
Source: Eur Respir Rev 2010 19: 261-263
Year: 2010
Surfactant protein D in serum from patients with allergic bronchopulmonary aspergillosis
Source: Eur Respir J 2003 Oct 01;22(4):592-595
Year: 2003
Effects and side effects of long term steroid therapy of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010
Bronchodilator responsiveness in children with cystic fibrosis and allergic bronchopulmonary aspergillosis
Source: Eur Respir J, 56 (2) 2000175; 10.1183/13993003.00175-2020
Year: 2020
Long term follow up of the lung function in cystic fibrosis patients with allergic bronchopulmonary aspergillosis (ABPA)
Source: Annual Congress 2009 - Cystic fibrosis: understanding a complex disease
Year: 2009
Association of pulmonary aspergilloma and allergic bronchopulmonary aspergillosis
Source: Eur Respir Rev 2010 19: 349-351
Year: 2010
Clinical presentation in 12 patients with allergic bronchopulmonary aspergillosis
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007
Treating allergic bronchopulmonary aspergillosis: the way forward
Source: Eur Respir J 2016; 47: 385-387
Year: 2016
Follow-up of patients with allergic bronchopulmonary aspergillosis (ABPA) - side effects of long-term therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 237s
Year: 2003
Risk factors for allergic bronchopulmonary aspergillosis in paediatric patients with cystic fibrosis
Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more
Year: 2010
Induced sputum IL-8 gene expression, neutrophil influx and MMP-9 in allergic bronchopulmonary aspergillosis
Source: Eur Respir J 2003; 21: 582-588
Year: 2003
Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosis
Source: Eur Respir J 2016; 47: 177-185
Year: 2016
Comparison of serum markers for allergic bronchopulmonary aspergillosis in cystic fibrosis
Source: Eur Respir J 2008; 31: 36-42
Year: 2008
Clinical characteristics and outcome of patients with allergic bronchopulmonary aspergillosis
Source: International Congress 2017 – Many faces of asthma and allergies
Year: 2017
Elevated CEA levels in sera in patients with allergic bronchopulmonary aspergillosis (ABPA)
Source: Annual Congress 2011 - Biomarkers of allergic inflammation
Year: 2011
Allergic bronchopulmonary aspergillosis and other fungal diseases
Source: Eur Respir Mon 2011; 52: 97-114
Year: 2011
Bronchopulmonary aspergillosis
Source: Respipedia Article
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept